252 related articles for article (PubMed ID: 9122101)
1. Ursodeoxycholic acid in the treatment of liver diseases.
Saksena S; Tandon RK
Postgrad Med J; 1997 Feb; 73(856):75-80. PubMed ID: 9122101
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid therapy in hepatobiliary disease.
Kowdley KV
Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
[TBL] [Abstract][Full Text] [Related]
3. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
Trauner M; Graziadei IW
Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
[TBL] [Abstract][Full Text] [Related]
4. Use of ursodeoxycholic acid in liver diseases.
Kumar D; Tandon RK
J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Serfaty L; Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
[No Abstract] [Full Text] [Related]
6. Use of ursodeoxycholic acid in patients with liver disease.
Angulo P
Curr Gastroenterol Rep; 2002 Feb; 4(1):37-44. PubMed ID: 11825540
[TBL] [Abstract][Full Text] [Related]
7. [New aspects of pharmacological effects of ursodeoxycholic acid].
Radchenko VG; Seliverstov PV; Sitkin SI
Eksp Klin Gastroenterol; 2014; (8):4-10. PubMed ID: 25911905
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
9. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
[No Abstract] [Full Text] [Related]
10. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
14. Does prophylactic ursodeoxycholic acid treatment of liver transplant patients prevent acute rejection?
Keiding S
Hepatology; 1998 Jun; 27(6):1748-9. PubMed ID: 9620354
[No Abstract] [Full Text] [Related]
15. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A
Curr Clin Pharmacol; 2007 May; 2(2):155-77. PubMed ID: 18690863
[TBL] [Abstract][Full Text] [Related]
17. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Luketic VA; Sanyal AJ
Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
[TBL] [Abstract][Full Text] [Related]
18. The ursodeoxycholic acid story in primary biliary cirrhosis.
Lim AG; Jazrawi RP; Northfield TC
Gut; 1995 Sep; 37(3):301-4. PubMed ID: 7590420
[No Abstract] [Full Text] [Related]
19. Primary sclerosing cholangitis.
Zein CO; Lindor KD
Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
[TBL] [Abstract][Full Text] [Related]
20. [Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope].
Olsson R
Lakartidningen; 2002 Mar; 99(12):1325-30. PubMed ID: 11998165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
